Neil B Hampson1, Susan L Dunn. 1. Center for Hyperbaric Medicine, Virginia Mason Medical Center, Seattle, Washington, USA. neil.hampson@vmmc.org
Abstract
BACKGROUND: Symptoms in carbon monoxide (CO) poisoned patients have traditionally been described as being related to corresponding carboxyhemoglobin (COHb) levels without substantive support for the relationship. This study sought to determine whether prospectively collected symptoms correlate with specific COHB level ranges in a large population of CO-poisoned patients. METHODS: Data from patients reported in the initial two years of operation of the joint UHMS/CDC CO Poisoning Surveillance System were used to compare presenting COHb levels with symptoms collected with a standardized questionnaire. RESULTS: Data from 1,323 CO-poisoned patients referred for hyperbaric oxygen therapy from August 2008 to July 2010 were analyzed with regard to initial COHb level and symptoms. Of approximately 50 categories of symptoms reported, none was associated with a specific range of COHb levels. CONCLUSIONS: While symptoms are common in acute CO poisoning, none can be directly correlated to COHb levels, even in a population of more than 1,000 patients. The concept of a table relating specific symptoms to specific COHb levels is invalid. One such table that has often been published comes from a 1923 U.S. government publication and appears to be based at least in part upon the symptoms experienced by three men in a total of 10 low-level laboratory CO exposures.
BACKGROUND: Symptoms in carbon monoxide (CO) poisoned patients have traditionally been described as being related to corresponding carboxyhemoglobin (COHb) levels without substantive support for the relationship. This study sought to determine whether prospectively collected symptoms correlate with specific COHB level ranges in a large population of CO-poisoned patients. METHODS: Data from patients reported in the initial two years of operation of the joint UHMS/CDC COPoisoning Surveillance System were used to compare presenting COHb levels with symptoms collected with a standardized questionnaire. RESULTS: Data from 1,323 CO-poisoned patients referred for hyperbaric oxygen therapy from August 2008 to July 2010 were analyzed with regard to initial COHb level and symptoms. Of approximately 50 categories of symptoms reported, none was associated with a specific range of COHb levels. CONCLUSIONS: While symptoms are common in acute CO poisoning, none can be directly correlated to COHb levels, even in a population of more than 1,000 patients. The concept of a table relating specific symptoms to specific COHb levels is invalid. One such table that has often been published comes from a 1923 U.S. government publication and appears to be based at least in part upon the symptoms experienced by three men in a total of 10 low-level laboratory CO exposures.
Authors: Derek M Culnan; Beretta Craft-Coffman; Genevieve H Bitz; Karel D Capek; Yiji Tu; William C Lineaweaver; Maggie J Kuhlmann-Capek Journal: Ann Plast Surg Date: 2018-03 Impact factor: 1.539
Authors: Satoshi Fukuda; Yosuke Niimi; Clark R Andersen; Ennert R Manyeza; Jose D Rojas; Donald S Prough; Perenlei Enkhbaatar Journal: Biochem Biophys Res Commun Date: 2020-03-18 Impact factor: 3.575
Authors: Jason J Rose; Kaitlin A Bocian; Qinzi Xu; Ling Wang; Anthony W DeMartino; Xiukai Chen; Catherine G Corey; Danielle A Guimarães; Ivan Azarov; Xueyin N Huang; Qin Tong; Lanping Guo; Mehdi Nouraie; Charles F McTiernan; Christopher P O'Donnell; Jesús Tejero; Sruti Shiva; Mark T Gladwin Journal: J Biol Chem Date: 2020-03-23 Impact factor: 5.157
Authors: Björn Jüttner; Hans-Jörg Busch; Andreas Callies; Harald Dormann; Thorsten Janisch; Guido Kaiser; Hella Körner-Göbel; Karsten Kluba; Stefan Kluge; Bernd A Leidel; Oliver Müller; Johannes Naser; Carsten Pohl; Karl Reiter; Dietmar Schneider; Enrico Staps; Wilhelm Welslau; Holger Wißuwa; Gabriele Wöbker; Cathleen Muche-Borowski Journal: Ger Med Sci Date: 2021-11-04